Transaction · 0001415889-25-006524

Peetz Christopher

Peetz Christopher, CEO, reported a transaction classified as exercise at Mirum Pharmaceuticals, Inc. involving 40000.000000 shares for an estimated $117440.00. Reported holdings after the transaction were 155920.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCEO
MIRMMirum Pharmaceuticals, Inc.
Filing timeMar 04
Trade dateMar 03, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

MIRM price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MIRM since 2025-03-04Filed 549 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001415889-25-006524
Common Stock
Transaction date
Mar 03, 2025
Filed Mar 04, 2025, 09:26 PM · 1d delay
Shares
40.0k sh
$294 per share
Estimated value
$11.7M
Computed from shares × price
Holdings after
155k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF EXECUTIVE OFFICER

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 22, 2024.

  2. F2

    The weighted average sale price for the transaction reported was $46.61, and the range of prices were between $45.82 and $46.81. Upon request by the SEC staff, the Issuer, or any security holder of th…

  3. F3

    The weighted average sale price for the transaction reported was $47.19, and the range of prices were between $46.82 and $47.78. Upon request by the SEC staff, the Issuer, or any security holder of th…

  4. F4

    The stock option is fully vested.

Original filing · 0001415889-25-006524
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MIRM